HIMSS24

Ran Balicer, HIMSS board of directors member, talks about the possibility of clinical digital support technology to personalize care by helping clinicians predict potential health issues for patients so they can be prevented.  

Dave Bailey, VP, Consulting Services at Clearwater Security, recommends developing cybersecurity strategy around a framework like NIST 2.0 and working with leadership to get the necessary resources to address vulnerabilities.  

McGill University Health Centre's Dr. Alan Forster discusses the Quadruple Aim and using data to understand opportunities for development and improvement.  

Dr. Calum Yacoubian, director of NLP healthcare strategy at IQVIA, says AI can support, not replace, clinicians in improving care delivery, and discusses some best practices for its safe and ethical use. The HIMSS AI in Healthcare Forum is scheduled to take place September 5-6 in Boston. Learn more and register.  

Kyruus Health president Paul Merrild discusses how the company aims to improve care access via its partnerships with health systems and payers and by pairing patients and providers using personalized information and provider availability.  

Robert Latz, CIO of Trinity Rehabilitation Services, discusses nursing homes' increased use of digital tools like automated cameras and how the HIMSS LTPAC committee is developing a prioritization tool to help facilities decide which tools to deploy.  

Oscar Alleyne, managing director of the public health division at MITRE, relays how federally funded research and development centers help public and private companies solve complex problems, including preparing for the next pandemic.  

David Wolf, MedeAnalytics AVP, and Lynn Carroll, HSBlox COO, highlight value-based care models' crucial components, including contract modeling and performance measurement, and discuss change management for switching to these models.  

Dr. John Showalter, Linus' chief product officer, discusses the company's cognitive impairment testing and care-delivery offerings for dementia diagnosis and treatment and its acquisition of speech analytics platform Aural Analytics.  

Ziv Ofek, cofounder and CEO of MDClone, discusses how GenAI tools may soon make it easier for clinicians to analyze synthetic data themselves if guardrails are in place to ensure that the AI's conclusions are correct.